nitrosobis(2-oxopropyl)amine has been researched along with Disease Exacerbation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grandhi, BK; Prabhu, S; Thakkar, A; Wang, J | 1 |
Furukawa, F; Hirose, M; Kanki, K; Kawamori, T; Lee, IS; Nishikawa, A; Okazaki, K; Umemura, T; Wakabayashi, K | 1 |
2 other study(ies) available for nitrosobis(2-oxopropyl)amine and Disease Exacerbation
Article | Year |
---|---|
A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspirin; Carcinogens; Cell Line, Tumor; Cricetinae; Curcumin; Disease Models, Animal; Disease Progression; Drug Delivery Systems; Immunohistochemistry; In Situ Nick-End Labeling; Isothiocyanates; Lipids; Male; Mesocricetus; Nanoparticles; Nitrosamines; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Sulfoxides | 2013 |
A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters.
Topics: Adenocarcinoma; Animals; Cell Transformation, Neoplastic; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Isoenzymes; Male; Mesocricetus; Nitrosamines; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Prostaglandin-Endoperoxide Synthases; Sulfonamides | 2003 |